BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leibovitz E, Piglansky L, Raiz S, Greenberg D, Hamed KA, Ledeine JM, Press J, Leiberman A, Echols RM, Pierce PF, Jacobs MR, Dagan R. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study. Pediatr Infect Dis J 2003;22:943-9. [PMID: 14614364 DOI: 10.1097/01.inf.0000095468.89866.14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Marchant CD. Gatifloxacin Therapy for Children: An Antibiotic Still in the "Back Room". Clinical Infectious Diseases 2005;41:479-80. [DOI: 10.1086/431596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Casey JR, Pichichero ME. Changes in Frequency and Pathogens Causing Acute Otitis Media in 1995–2003. Pediatric Infectious Disease Journal 2004;23:824-8. [DOI: 10.1097/01.inf.0000136871.51792.19] [Cited by in Crossref: 312] [Cited by in F6Publishing: 260] [Article Influence: 17.3] [Reference Citation Analysis]
3 Sáez-llorens X, Rodriguez A, Arguedas A, Hamed KA, Yang J, Pierce P, Echols R. Randomized, Investigator-Blinded, Multicenter Study of Gatifloxacin Versus Amoxicillin/Clavulanate Treatment of Recurrent and Nonresponsive Otitis Media in Children. Pediatric Infectious Disease Journal 2005;24:293-300. [DOI: 10.1097/01.inf.0000157088.37864.e6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 LaCross NC, Marrs CF, Gilsdorf JR. Population structure in nontypeable Haemophilus influenzae. Infect Genet Evol 2013;14:125-36. [PMID: 23266487 DOI: 10.1016/j.meegid.2012.11.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
5 Weimer KE, Juneau RA, Murrah KA, Pang B, Armbruster CE, Richardson SH, Swords WE. Divergent mechanisms for passive pneumococcal resistance to β-lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis 2011;203:549-55. [PMID: 21220774 DOI: 10.1093/infdis/jiq087] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
6 Davies TA, Leibovitz E, Noel GJ, McNeeley DF, Bush K, Dagan R. Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin. Antimicrob Agents Chemother 2008;52:378-81. [PMID: 17999965 DOI: 10.1128/AAC.01068-07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 . Announcement: 2005 Certifying Examination in Pediatric Infectious Diseases. Pediatric Infectious Disease Journal 2004;23:841. [DOI: 10.1097/01.inf.0000138453.32886.a6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Pichichero ME, Casey JR. Comparison of study designs for acute otitis media trials. International Journal of Pediatric Otorhinolaryngology 2008;72:737-50. [DOI: 10.1016/j.ijporl.2008.02.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
9 Sabharwal V, Marchant CD. Fluoroquinolone Use in Children: . The Pediatric Infectious Disease Journal 2006;25:257-8. [DOI: 10.1097/01.inf.0000205799.35780.f3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
10 Pelton SI. Otitis media: re-evaluation of diagnosis and treatment in the era of antimicrobial resistance, pneumococcal conjugate vaccine, and evolving morbidity. Pediatr Clin North Am 2005;52:711-28, v-vi. [PMID: 15925659 DOI: 10.1016/j.pcl.2005.02.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dagan R, Arguedas A, Schaad UB. Potential Role of Fluoroquinolone Therapy in Childhood Otitis Media: . The Pediatric Infectious Disease Journal 2004;23:390-8. [DOI: 10.1097/01.inf.0000126272.08795.7a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
12 Kilpi T, Schuerman L. Acute Otitis Media and Its Sequelae. In: Siber GR, Klugman KP, Helena Mäkelä P, editors. Pneumococcal Vaccines. Washington: ASM Press; 2008. pp. 301-15. [DOI: 10.1128/9781555815820.ch20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Sandstedt SA, Marrs CF, Patel M, Hirasawa H, Zhang L, Davis GS, Gilsdorf JR. Prevalence of Haemophilus influenzae type b genetic islands among clinical and commensal H. influenzae and H. haemolyticus isolates. J Clin Microbiol 2010;48:2565-8. [PMID: 20463164 DOI: 10.1128/JCM.02453-09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Schaad UB. Fluoroquinolone Antibiotics in Infants and Children. Infectious Disease Clinics of North America 2005;19:617-28. [DOI: 10.1016/j.idc.2005.05.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
15 O'donnell JA, Gelone SP. The newer fluoroquinolones. Infectious Disease Clinics of North America 2004;18:691-716. [DOI: 10.1016/j.idc.2004.04.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
16 Sansone JM, Wilsman NJ, Leiferman EM, Conway J, Hutson P, Noonan KJ. The effect of fluoroquinolone antibiotics on growing cartilage in the lamb model. J Pediatr Orthop 2009;29:189-95. [PMID: 19352246 DOI: 10.1097/BPO.0b013e3181982c4f] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Leibovitz E. Acute otitis media in children aged less than 2 years: drug treatment issues. Paediatr Drugs 2006;8:337-46. [PMID: 17154641 DOI: 10.2165/00148581-200608060-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
18 Soley C, Arguedas A, Porras W, Guevara S, Loaiza C, Pérez A, Rincón G, Schultz M, Arguedas J, Brilla R. In vitro activities of levofloxacin and comparable agents against middle ear fluid, nasopharyngeal, and oropharyngeal pathogens obtained from Costa Rican children with recurrent otitis media or failing other antibiotic therapy. Antimicrob Agents Chemother 2005;49:3056-8. [PMID: 15980399 DOI: 10.1128/AAC.49.7.3056-3058.2005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Grant GB, Campbell H, Dowell SF, Graham SM, Klugman KP, Mulholland EK, Steinhoff M, Weber MW, Qazi S; World Health Organization Department of Child and Adolescent Health and Development. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect Dis 2009;9:185-96. [PMID: 19246022 DOI: 10.1016/S1473-3099(09)70044-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
20 Dagan R, Schneider S, Givon-lavi N, Greenberg D, Leiberman A, Jacobs MR, Leibovitz E. Failure to Achieve Early Bacterial Eradication Increases Clinical Failure Rate in Acute Otitis Media in Young Children. Pediatric Infectious Disease Journal 2008;27:200-6. [DOI: 10.1097/inf.0b013e31815c1b1d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
21 Arguedas A, Dagan R, Pichichero M, Leibovitz E, Blumer J, Mcneeley DF, Melkote R, Noel GJ. An Open-Label, Double Tympanocentesis Study of Levofloxacin Therapy in Children With, or at High Risk for, Recurrent or Persistent Acute Otitis Media: . The Pediatric Infectious Disease Journal 2006;25:1102-9. [DOI: 10.1097/01.inf.0000246828.13834.f9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
22 Asher E, Dagan R, Greenberg D, Givon-lavi N, Libson S, Porat N, Leiberman A, Leibovitz E. Persistence of Pathogens Despite Clinical Improvement in Antibiotic-Treated Acute Otitis Media Is Associated With Clinical and Bacteriologic Relapse. Pediatric Infectious Disease Journal 2008;27:296-301. [DOI: 10.1097/inf.0b013e31815ed79c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Aliphas A, Prufer N, Grundfast KM. Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs 2006;11:251-64. [PMID: 16634700 DOI: 10.1517/14728214.11.2.251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
24 Noel GJ, Blumer JL, Pichichero ME, Hedrick JA, Schwartz RH, Balis DA, Melkote R, Bagchi P, Arguedas A. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media. Pediatr Infect Dis J 2008;27:483-9. [PMID: 18449063 DOI: 10.1097/INF.0b013e318168d2cb] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Noel GJ, Bradley JS, Kauffman RE, Duffy CM, Gerbino PG, Arguedas A, Bagchi P, Balis DA, Blumer JL. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders. Pediatr Infect Dis J 2007;26:879-91. [PMID: 17901792 DOI: 10.1097/INF.0b013e3180cbd382] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
26 Leibovitz E, Nakash E, Givon-lavi N, Greenberg D, Satran R, Raiz S, Piglansky L, Leiberman A, Dagan R. Clinical Outcome in Children With Culture-Negative Acute Otitis Media. Pediatric Infectious Disease Journal 2009;28:1105-10. [DOI: 10.1097/inf.0b013e3181b20e7a] [Cited by in Crossref: 9] [Article Influence: 0.7] [Reference Citation Analysis]
27 Segal N, Leibovitz E, Dagan R, Leiberman A. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 2005;69:1311-9. [PMID: 15955573 DOI: 10.1016/j.ijporl.2005.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
28 Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review. PLoS One 2016;11:e0150949. [PMID: 26953891 DOI: 10.1371/journal.pone.0150949] [Cited by in Crossref: 98] [Cited by in F6Publishing: 85] [Article Influence: 16.3] [Reference Citation Analysis]
29 Sher L, Arguedas A, Husseman M, Pichichero M, Hamed KA, Biswas D, Pierce P, Echols R. Randomized, Investigator-Blinded, Multicenter, Comparative Study of Gatifloxacin Versus Amoxicillin/Clavulanate in Recurrent Otitis Media and Acute Otitis Media Treatment Failure in Children. Pediatric Infectious Disease Journal 2005;24:301-8. [DOI: 10.1097/01.inf.0000157084.35865.ba] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
30 Leibovitz E, Asher E, Piglansky L, Givon-Lavi N, Satran R, Raiz S, Slovik Y, Leiberman A, Dagan R. Is bilateral acute otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J 2007;26:589-92. [PMID: 17596799 DOI: 10.1097/INF.0b013e318060cc19] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
31 Juliao PC, Marrs CF, Xie J, Gilsdorf JR. Histidine auxotrophy in commensal and disease-causing nontypeable Haemophilus influenzae. J Bacteriol 2007;189:4994-5001. [PMID: 17496076 DOI: 10.1128/JB.00146-07] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
32 Rubino CM, Capparelli EV, Bradley JS, Blumer JL, Kearns GL, Reed M, Jacobs RF, Cirincione B, Grasela DM. Population pharmacokinetic model for gatifloxacin in pediatric patients. Antimicrob Agents Chemother 2007;51:1246-52. [PMID: 17220409 DOI: 10.1128/AAC.00685-06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Barkai G, Leibovitz E, Givon-Lavi N, Dagan R. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr Infect Dis J 2009;28:466-71. [PMID: 19504729 DOI: 10.1097/inf.0b013e3181950c74] [Cited by in Crossref: 60] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]